MONOPHARMA Stock Overview
Engages in the marketing and distribution of pharmaceutical products in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Mono Pharmacare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹33.20 |
| 52 Week High | ₹75.00 |
| 52 Week Low | ₹32.80 |
| Beta | 0 |
| 11 Month Change | -4.05% |
| 3 Month Change | -16.16% |
| 1 Year Change | -26.22% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 9.03% |
Recent News & Updates
We Think Mono Pharmacare (NSE:MONOPHARMA) Is Taking Some Risk With Its Debt
Sep 26
Market Still Lacking Some Conviction On Mono Pharmacare Limited (NSE:MONOPHARMA)
Aug 11Shareholder Returns
| MONOPHARMA | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -5.1% | 0.8% | 0.3% |
| 1Y | -26.2% | 36.4% | 27.3% |
Return vs Industry: MONOPHARMA underperformed the Indian Healthcare industry which returned 36.4% over the past year.
Return vs Market: MONOPHARMA underperformed the Indian Market which returned 27.3% over the past year.
Price Volatility
| MONOPHARMA volatility | |
|---|---|
| MONOPHARMA Average Weekly Movement | 8.1% |
| Healthcare Industry Average Movement | 5.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: MONOPHARMA's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: MONOPHARMA's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | n/a | Panilam Lakhatariya | monopharmacareltd.com |
Mono Pharmacare Limited engages in the marketing and distribution of pharmaceutical products in India. The company offers products in various categories, such as antibiotics, anti-fungal, anti cough- cold and anti-allergic, antacid and antiemetics, analgesic and antipyretic, nutraceuticals, skin care, antiseptic, cardiac and diabetics, cosmetics, etc. It also sells its pharmaceutical products under the DLS Export brand name. The company was founded in 1994 and is based in Ahmedabad, India.
Mono Pharmacare Limited Fundamentals Summary
| MONOPHARMA fundamental statistics | |
|---|---|
| Market cap | ₹587.48m |
| Earnings (TTM) | ₹24.42m |
| Revenue (TTM) | ₹1.22b |
24.0x
P/E Ratio0.5x
P/S RatioIs MONOPHARMA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MONOPHARMA income statement (TTM) | |
|---|---|
| Revenue | ₹1.22b |
| Cost of Revenue | ₹1.11b |
| Gross Profit | ₹117.60m |
| Other Expenses | ₹93.17m |
| Earnings | ₹24.42m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.38 |
| Gross Margin | 9.60% |
| Net Profit Margin | 1.99% |
| Debt/Equity Ratio | 147.3% |
How did MONOPHARMA perform over the long term?
See historical performance and comparison